Simon Thezenas

5PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Fairness, accountability, transparency, trust and ethics of computer systemsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2025
Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial.

Marie Vinches, Chloé Janiszewski, Simon Thezenas

|Dec 04, 2025
Screening for reduced food intake in 2 minutes: validation of the ingesta verbal analogue scale in medical geriatric oncology.

Pierre Senesse, Julie Deffrennes, Nicolas Flori

|Feb 24, 2024
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.

Julien Guérin, Amine Nahid, Louis Tassy

|Sep 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.

Pascale Palassin, Marion Lapierre, Samuel Pyrdziak

|Sep 23, 2020
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Ileana Corbeau, Simon Thezenas, Aurelie Maran-Gonzalez

Pageof 1

Frequent Collaborators

2 joint publications

Chloé Janiszewski

2 joint publications

Pierre Senesse

1 joint publications

William Jacot

1 joint publications

Pascale Palassin